XML 52 R28.htm IDEA: XBRL DOCUMENT v2.4.0.6
Supplemental Guarantor and Non-Guarantor Financial Information
12 Months Ended
Dec. 31, 2012
Supplemental Guarantor and Non-Guarantor Financial Information [Abstract]  
Supplemental Guarantor and Non-Guarantor Financial Information
Supplemental Guarantor and Non-Guarantor Financial Information
Gentiva’s guarantor subsidiaries are guarantors to the Company’s debt securities which are registered under the Securities Act of 1933, as amended. The condensed consolidating financial statements presented below are provided pursuant to Rule 3-10 of Regulation S-X. Separate financial statements of each subsidiary guaranteeing Gentiva’s debt securities are not presented because the guarantor subsidiaries are jointly and severally, fully and unconditionally liable under the guarantees, subject to certain customary release provisions and 100 percent owned by the Company. There are no restrictions on the ability to obtain funds from these subsidiaries by dividends or other means.
The following condensed consolidating financial statements include the balance sheets as of December 31, 2012 and December 31, 2011, statements of comprehensive income for the years ended December 31, 2012December 31, 2011 and December 31, 2010 and statements of cash flows for the years ended December 31, 2012December 31, 2011 and December 31, 2010 of (i) Gentiva Health Services, Inc., (ii) its guarantor subsidiaries, and (iii) its non-guarantor subsidiaries, (in each case, reflecting investments in its consolidated subsidiaries under the equity method of accounting) along with eliminations necessary to arrive at the information for the Company on a consolidated basis. Odyssey and its 100 percent owned subsidiaries are reflected as guarantor subsidiaries and Odyssey’s majority owned subsidiaries are reflected as non-guarantor subsidiaries in the condensed consolidating financial statements from August 17, 2010. The condensed consolidating financial statements should be read in conjunction with the accompanying consolidated financial statements.
Condensed Consolidating Balance Sheet
December 31, 2012
(In thousands)
 
 
Gentiva Health
Services, Inc.
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Total
ASSETS
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
166,140

 
$

 
$
40,912

 
$

 
$
207,052

Receivables, net

 
245,191

 
19,744

 
(13,855
)
 
251,080

Deferred tax assets, net

 
10,280

 
1,983

 

 
12,263

Prepaid expenses and other current assets

 
36,899

 
8,733

 

 
45,632

Total current assets
166,140

 
292,370

 
71,372

 
(13,855
)
 
516,027

Notes receivable from CareCentrix

 
28,471

 

 

 
28,471

Fixed assets, net

 
41,066

 
348

 

 
41,414

Intangible assets, net

 
193,513

 
100

 

 
193,613

Goodwill

 
650,300

 
6,064

 

 
656,364

Investment in subsidiaries
1,002,204

 
27,210

 

 
(1,029,414
)
 

Other assets

 
75,039

 
6

 

 
75,045

Total assets
$
1,168,344

 
$
1,307,969

 
$
77,890

 
$
(1,043,269
)
 
$
1,510,934

LIABILITIES AND EQUITY
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
Current portion of long-term debt
$
25,000

 
$

 
$

 
$

 
$
25,000

Accounts payable

 
27,300

 

 
(13,855
)
 
13,445

Other current liabilities

 
202,321

 
49,133

 

 
251,454

Total current liabilities
25,000

 
229,621

 
49,133

 
(13,855
)
 
289,899

Long-term debt
910,182

 

 

 

 
910,182

Deferred tax liabilities, net

 
42,165

 

 

 
42,165

Other liabilities

 
33,979

 
9

 

 
33,988

Total Gentiva shareholders’ equity
233,162

 
1,002,204

 
27,210

 
(1,029,414
)
 
233,162

Noncontrolling interests

 

 
1,538

 

 
1,538

Total equity
233,162

 
1,002,204

 
28,748

 
(1,029,414
)
 
234,700

Total liabilities and equity
$
1,168,344

 
$
1,307,969

 
$
77,890

 
$
(1,043,269
)
 
$
1,510,934

Condensed Consolidating Balance Sheet
December 31, 2011
(In thousands)
 
 
Gentiva Health
Services, Inc.
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Total
ASSETS
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
124,101

 
$

 
$
40,811

 
$

 
$
164,912

Receivables, net

 
283,552

 
18,168

 
(11,131
)
 
290,589

Deferred tax assets, net

 
24,560

 
1,891

 

 
26,451

Prepaid expenses and other current assets

 
32,619

 
6,904

 
(1,144
)
 
38,379

Total current assets
124,101

 
340,731

 
67,774

 
(12,275
)
 
520,331

Note receivable from CareCentrix

 
25,000

 

 

 
25,000

Fixed assets, net

 
45,917

 
329

 

 
46,246

Intangible assets, net

 
214,774

 
100

 

 
214,874

Goodwill

 
635,605

 
6,064

 

 
641,669

Investment in subsidiaries
1,063,962

 
25,173

 

 
(1,089,135
)
 

Other assets

 
82,200

 
8

 

 
82,208

Total assets
$
1,188,063

 
$
1,369,400

 
$
74,275

 
$
(1,101,410
)
 
$
1,530,328

LIABILITIES AND EQUITY
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
Current portion of long-term debt
$
14,903

 
$

 
$

 
$

 
$
14,903

Accounts payable

 
22,913

 
831

 
(11,131
)
 
12,613

Other current liabilities

 
223,165

 
45,655

 
(1,144
)
 
267,676

Total current liabilities
14,903

 
246,078

 
46,486

 
(12,275
)
 
295,192

Long-term debt
973,222

 

 

 

 
973,222

Deferred tax liabilities, net

 
32,498

 

 

 
32,498

Other liabilities

 
26,862

 
23

 

 
26,885

Total Gentiva shareholders’ equity
199,938

 
1,063,962

 
25,173

 
(1,089,135
)
 
199,938

Noncontrolling interests

 

 
2,593

 

 
2,593

Total equity
199,938

 
1,063,962

 
27,766

 
(1,089,135
)
 
202,531

Total liabilities and equity
$
1,188,063

 
$
1,369,400

 
$
74,275

 
$
(1,101,410
)
 
$
1,530,328


Condensed Consolidating Statement of Comprehensive Income
For the Year Ended December 31, 2012
(In thousands)
 
 
Gentiva Health
Services, Inc.
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Total
Net revenues
$

 
$
1,666,368

 
$
61,656

 
$
(15,220
)
 
$
1,712,804

Cost of services sold

 
884,903

 
39,058

 
(15,220
)
 
908,741

Gross profit

 
781,465

 
22,598

 

 
804,063

Selling, general and administrative expenses

 
(638,975
)
 
(16,791
)
 

 
(655,766
)
Goodwill, intangibles and other long-lived asset impairment

 
(19,132
)
 

 

 
(19,132
)
Gain on sale of assets and businesses, net

 
8,014

 

 

 
8,014

Interest (expense) and other, net
(90,054
)
 

 
107

 

 
(89,947
)
Equity in earnings of subsidiaries
79,622

 
3,038

 

 
(82,660
)
 

(Loss) income from continuing operations before income taxes and equity in net earnings of CareCentrix
(10,432
)
 
134,410

 
5,914

 
(82,660
)
 
47,232

Income tax benefit (expense)
37,228

 
(52,487
)
 
(1,992
)
 

 
(17,251
)
Equity in net (loss) earnings of CareCentrix

 
(2,301
)
 

 

 
(2,301
)
Income from continuing operations
26,796

 
79,622

 
3,922

 
(82,660
)
 
27,680

Discontinued operations, net of tax

 

 

 

 

Net income
26,796

 
79,622

 
3,922

 
(82,660
)
 
27,680

Noncontrolling interests

 

 
(884
)
 

 
(884
)
Net income attributable to Gentiva shareholders
$
26,796

 
$
79,622

 
$
3,038

 
$
(82,660
)
 
$
26,796

Comprehensive income
$
26,796

 
$
79,622

 
$
3,922

 
$
(82,660
)
 
$
27,680

Condensed Consolidating Statement of Comprehensive Income
For the Year Ended December 31, 2011
(In thousands)
 
 
Gentiva Health
Services, Inc.
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Total
Net revenues
$

 
$
1,757,459

 
$
52,404

 
$
(11,085
)
 
$
1,798,778

Cost of services sold

 
921,826

 
37,714

 
(11,085
)
 
948,455

Gross profit

 
835,633

 
14,690

 

 
850,323

Selling, general and administrative expenses

 
(715,343
)
 
(15,064
)
 

 
(730,407
)
Goodwill, intangibles and other long-lived asset impairment

 
(643,305
)
 

 

 
(643,305
)
Gain on sale of assets and businesses, net

 
1,061

 

 

 
1,061

Dividend income

 
8,590

 

 

 
8,590

Interest (expense) and other, net
(88,665
)
 

 
55

 

 
(88,610
)
Equity in earnings of subsidiaries
(380,176
)
 
221

 

 
379,955

 

Loss from continuing operations before income taxes and equity in net earnings of CareCentrix
(468,841
)
 
(513,143
)
 
(319
)
 
379,955

 
(602,348
)
Income tax benefit (expense)
18,316

 
56,637

 
815

 

 
75,768

Equity in net earnings of CareCentrix

 
68,381

 

 

 
68,381

(Loss) income from continuing operations
(450,525
)
 
(388,125
)
 
496

 
379,955

 
(458,199
)
Discontinued operations, net of tax

 
7,949

 
366

 

 
8,315

Net (loss) income
(450,525
)
 
(380,176
)
 
862

 
379,955

 
(449,884
)
Noncontrolling interests

 

 
(641
)
 

 
(641
)
Net (loss) income attributable to Gentiva shareholders
$
(450,525
)
 
$
(380,176
)
 
$
221

 
$
379,955

 
$
(450,525
)
Comprehensive (loss) income
$
(451,003
)
 
$
(380,176
)
 
$
862

 
$
379,955

 
$
(450,362
)
Condensed Consolidating Statement of Comprehensive Income
For the Year Ended December 31, 2010
(In thousands)
 
 
Gentiva Health
Services, Inc.
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Total
Net revenues
$

 
$
1,388,234

 
$
38,463

 
$
(12,238
)
 
$
1,414,459

Cost of services sold

 
667,389

 
24,923

 
(12,238
)
 
680,074

Gross profit

 
720,845

 
13,540

 

 
734,385

Selling, general and administrative expenses

 
(596,874
)
 
(9,990
)
 

 
(606,864
)
Gain on sale of businesses

 
103

 

 

 
103

Interest (expense) and other, net
(39,097
)
 

 
67

 

 
(39,030
)
Equity in earnings of subsidiaries
75,652

 
2,033

 

 
(77,685
)
 

Income from continuing operations before income taxes and equity in net earnings of CareCentrix
36,555

 
126,107

 
3,617

 
(77,685
)
 
88,594

Income tax benefit (expense)
15,600

 
(48,336
)
 
(1,340
)
 

 
(34,076
)
Equity in net earnings of CareCentrix

 
1,298

 

 

 
1,298

Income from continuing operations
52,155

 
79,069

 
2,277

 
(77,685
)
 
55,816

Discontinued operations, net of tax

 
(3,417
)
 
282

 

 
(3,135
)
Net income
52,155

 
75,652

 
2,559

 
(77,685
)
 
52,681

Noncontrolling interests

 

 
(526
)
 

 
(526
)
Net income attributable to Gentiva shareholders
$
52,155

 
$
75,652

 
$
2,033

 
$
(77,685
)
 
$
52,155

Comprehensive income
$
52,633

 
$
75,652

 
$
2,559

 
$
(77,685
)
 
$
53,159



Condensed Consolidating Statement of Cash Flows
For the Year Ended December 31, 2012
(In thousands)
 
 
Gentiva Health
Services, Inc.
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Total
OPERATING ACTIVITIES:
 
 
 
 
 
 
 
 
 
Net cash (used in) provided by operating activities
$
(18,089
)
 
$
138,316

 
$
5,741

 
$

 
$
125,968

INVESTING ACTIVITIES:
 
 
 
 
 
 
 
 
 
Purchase of fixed assets

 
(11,609
)
 
(170
)
 

 
(11,779
)
Proceeds from sale of businesses

 
9,220

 

 

 
9,220

Acquisition of businesses

 
(22,335
)
 

 

 
(22,335
)
Net cash used in investing activities

 
(24,724
)
 
(170
)
 

 
(24,894
)
FINANCING ACTIVITIES:
 
 
 
 
 
 
 
 
 
Proceeds from issuance of common stock
3,980

 

 

 

 
3,980

Windfall tax benefits associated with equity-based compensation
88

 

 

 

 
88

Repayment of long-term debt
(52,943
)
 

 

 

 
(52,943
)
Debt issuance costs
(4,125
)
 

 

 

 
(4,125
)
Repurchase of common stock
(4,974
)
 

 

 

 
(4,974
)
Repayment of capital lease obligations
(135
)
 

 

 

 
(135
)
Other
4,673

 
(28
)
 
(5,470
)
 

 
(825
)
Net payments related to intercompany financing
113,564

 
(113,564
)
 

 

 

Net cash provided by (used in) financing activities
60,128

 
(113,592
)
 
(5,470
)
 

 
(58,934
)
Net change in cash and cash equivalents
42,039

 

 
101

 

 
42,140

Cash and cash equivalents at beginning of period
124,101

 

 
40,811

 

 
164,912

Cash and cash equivalents at end of period
$
166,140

 
$

 
$
40,912

 
$

 
$
207,052


Condensed Consolidating Statement of Cash Flows
For the Year Ended December 31, 2011
(In thousands)
 

Gentiva Health
Services, Inc.
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Total
OPERATING ACTIVITIES:
 
 
 
 
 
 
 
 
 
Net cash (used in) provided by operating activities
$
(46,730
)
 
$
51,221

 
$
650

 
$

 
$
5,141

INVESTING ACTIVITIES:
 
 
 
 
 
 
 
 
 
Purchase of fixed assets

 
(19,053
)
 
(178
)
 

 
(19,231
)
Proceeds from sale of businesses

 
146,261

 
54

 

 
146,315

Acquisition of businesses

 
(320
)
 

 

 
(320
)
Net cash provided by (used in) investing activities

 
126,888

 
(124
)
 

 
126,764

FINANCING ACTIVITIES:
 
 
 
 
 
 
 
 
 
Proceeds from issuance of common stock
7,901

 

 

 

 
7,901

Windfall tax benefits associated with equity-based compensation
192

 

 

 

 
192

Repayment of long-term debt
(63,438
)
 

 

 

 
(63,438
)
Debt issuance costs
(15,460
)
 

 

 

 
(15,460
)
Repayment of capital lease obligations
(267
)
 

 

 

 
(267
)
Other

 
(22
)
 
(651
)
 

 
(673
)
Net payments related to intercompany financing
178,087

 
(178,087
)
 

 

 

Net cash provided by (used in) financing activities
107,015

 
(178,109
)
 
(651
)
 

 
(71,745
)
Net change in cash and cash equivalents
60,285

 

 
(125
)
 

 
60,160

Cash and cash equivalents at beginning of period
63,816

 

 
40,936

 

 
104,752

Cash and cash equivalents at end of period
$
124,101

 
$

 
$
40,811

 
$

 
$
164,912


Condensed Consolidating Statement of Cash Flows
For the Year Ended December 31, 2010
(In thousands)
 
 
Gentiva Health
Services, Inc.
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Total
OPERATING ACTIVITIES:
 
 
 
 
 
 
 
 
 
Net cash (used in) provided by operating activities
$
(13,150
)
 
$
156,227

 
$
(456
)
 
$

 
$
142,621

INVESTING ACTIVITIES:
 
 
 
 
 
 
 
 
 
Purchase of fixed assets

 
(15,947
)
 
(237
)
 

 
(16,184
)
Proceeds from sale of businesses

 
9,796

 

 

 
9,796

Acquisition of businesses

 
(834,919
)
 

 

 
(834,919
)
Net cash used in investing activities

 
(841,070
)
 
(237
)
 

 
(841,307
)
FINANCING ACTIVITIES:
 
 
 
 
 
 
 
 
 
Proceeds from issuance of common stock
8,618

 

 

 

 
8,618

Windfall tax benefits associated with equity-based compensation
948

 

 

 

 
948

Proceeds from issuance of debt
1,075,000

 

 

 

 
1,075,000

Borrowings under revolving credit facility
30,000

 

 

 

 
30,000

Repayment under revolving credit facility
(30,000
)
 

 

 

 
(30,000
)
Repayment of long-term debt
(260,437
)
 

 

 

 
(260,437
)
Repayment of Odyssey long-term debt

 
(108,822
)
 

 

 
(108,822
)
Debt issuance costs
(58,577
)
 

 

 

 
(58,577
)
Repurchase of common stock
(4,985
)
 

 

 

 
(4,985
)
Repayment of capital lease obligations
(645
)
 

 

 

 
(645
)
Other
(72
)
 

 

 

 
(72
)
Net payments related to intercompany financing
(796,095
)
 
793,665

 
2,430

 

 

Net cash (used in) provided by financing activities
(36,245
)
 
684,843

 
2,430

 

 
651,028

Net change in cash and cash equivalents
(49,395
)
 

 
1,737

 

 
(47,658
)
Cash and cash equivalents at beginning of period
113,211

 

 
39,199

 

 
152,410

Cash and cash equivalents at end of period
$
63,816

 
$

 
$
40,936

 
$

 
$
104,752